Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Mol Cancer Ther

From Bioblast
Journals in Bioblast
Journal title and website Molecular Cancer Therapeutics

Publications

 ReferencePublishedView
Teh 2019 Mol Cancer TherTeh JT, Zhu WL, Newgard CB, Casey PJ, Wang M (2019) Respiratory capacity and reserve predict cell sensitivity to mitochondria inhibitors: mechanism-based markers to identify metformin-responsive cancers. Mol Cancer Ther 18:693-705.2019PMID: 30824582 Open Access
Schlaepfer 2014 Mol Cancer TherSchlaepfer IR, Rider L, Rodrigues LU, Gijón MA, Pac CT, Romero L, Cimic A, Sirintrapun SJ, Glodé LM, Eckel RH, Cramer SD (2014) Lipid catabolism via CPT1 as a therapeutic target for prostate cancer. Mol Cancer Ther 13:2361-71.2014PMID:25122071 Open Access